Childhood T Acute Lymphoblastic Leukemia: Clinical Trials

1 trial for Childhood T Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Childhood T Acute Lymphoblastic Leukemia: new trials by email Literature Review of Childhood T Acute Lymphoblastic Leukemia trials Research Report on Childhood T Acute Lymphoblastic Leukemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Dexamethasone, Laboratory Biomarker Analysis, Methotrexate - Childhood B Acute Lymphoblastic Leukemia, Childhood T Acute Lymphoblastic Leukemia
Phase 1CompletedNational Cancer Institute (NCI)132011-09-012015-07-10

Narrower conditions

Lymphoma, T-Cell (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Methotrexate (1)  ·  Mitoxantrone (1)  ·  Sirolimus (1)  ·  Vincristine (1)  ·  auricularum (1)  ·  dexamethasone 21-phosphate (1)  ·  dexamethasone acetate (1)  ·  merphos (1)  ·  pegaspargase (1)  ·  temsirolimus (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

Canada (1)  ·  United States (1)

Top investigators

Susan Rheingold (1)

NIH funding

U01CA097452 (1)